Identification of G-protein-coupled receptors involved in inflammatory disease by genetic association studies

Current Opinion in Pharmacology

Volumn 5, Issue 4 SPEC. ISS., 2005, Pages 412-417

  Pettipher, Roy ^a   Mangion, Jon ^a   Hunter, Michael G ^a   Mackay, Ian ^a  

^a Oxagen Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR;

BIOLOGICAL ACTIVITY; DISEASE PREDISPOSITION; DRUG INDICATION; DRUG TARGETING; GENETIC ASSOCIATION; HUMAN; INFLAMMATORY DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM; PROTEIN VARIANT; REVIEW;

EID: 21644467901     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2005.03.005     Document Type: Review

References (37)

1. B. Kerem J.M. Rommens J.A. Buchanan D. Markiewicz T.K. Cox A. Chakravarti M. Buchwald L.C. Tsui Identification of the cystic fibrosis gene: Genetic analysis Science 245 1989 1073-1080
2. J.R. Riordan J.M. Rommens B. Kerem N. Alon R. Rozmahel Z. Grzelczak J. Zielenski S. Lok N. Plavsic J.L. Chou et al. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA Science 245 1989 1066-1073
3. D. Botstein N. Risch Discovering genotypes underlying human phenotypes: past successes for Mendelian disease, future approaches for complex disease Nat Genet 33 2003 228-237
4. J.P. Hugot M. Chamaillard H. Zouali S. Lesage J.P. Cezard J. Belaiche S. Almer C. Tysk C.A. O'Morain M. Gassull et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease Nature 411 2001 599-603
5. A.L. Hopkins C.R. Groom The druggable genome Nat Rev Drug Discov 1 2002 727-730
6. A.K. Daly Candidate gene case-control studies Pharmacogenomics 4 2003 127-139
7. L.R. Cardon J.I. Bell Association study designs for complex disease Nat Rev Genet 2 2001 91-99
8. K.T. Zondervan L.R. Cardon S.H. Kennedy What makes a good case-control study? Design issues for complex traits such as endometriosis Hum Reprod 17 2002 1415-1423
9. A. Wise K. Gearing S. Rees Target validation of G-protein coupled receptors Drug Discov Today 7 2002 235-246
10. T. Schoneberg A. Schulz H. Biebermann T. Hermsdorf H. Rompler K. Sangkuhl Mutant G-protein-coupled receptors as a cause of human diseases Pharmacol Ther 104 2004 173-206
11. D.M. Perez Polymorphic G-protein-coupled receptors and associated diseases Receptors Channels 8 2002 57-64
12. A. Lee B.K. Rana H.H. Schiffer N.J. Schlork M.R. Brann P.A. Insel D.M. Weiner Distribution analysis of nonsynonymous polymorphisms within the G-protein -coupled receptor gene family Genomics 81 2003 245-248
13. K.M. Small D.A. Tanguay K. Nandabalan P. Zhan J.C. Stephens S.B. Liggett Gene and protein domain-specific patterns of genetic variability within the G-protein coupled receptor superfamily Am J Pharmacogenomics 3 2003 65-71
14. K.M. Small S.B. Liggett Identification and functional characterisation of a2-adrenoceptor polymorphisms Trends Pharmacol Sci 22 2001 471-477
15. R. Seifert K. Wenzel-Seifert Constitutive activity of G-protein-coupled receptors:cause of disease and common property of wild-type receptors Naunyn Schmiedebergs Arch Pharmacol 366 2002 381-416
16. G. Lucotte G. Mercier Distribution of the CCR5 gene 32-bp deletion in Europe J Acquir Immune Defic Syndr Hum Retrovirol 19 1998 174-177
17. A.E.I. Proudfoot Chemokine receptors: Multifaceted therapeutic targets Nat Rev Immunol 2 2002 106-115
18. G. Alkhatib C. Combadiere C.C. Broder Y. Feng P.E. Kennedy P.M. Murphy E.A. Berger CC CKR5: A RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1 Science 272 1996 1955-1958
19. H. Deng R. Liu W. Ellmeier S. Choe D. Unutmaz M. Burkhart P. Di Marzio S. Marmon R.E. Sutton C.M. Hill et al. Identification of a major co-receptor for primary isolates of HIV-1 Nature 381 1996 661-666
20. F. Cocchi A.L. DeVico A. Garzino-Demo S.K. Arya R.C. Gallo P. Lusso Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells Science 270 1995 1811-1815
21. M. Dean M. Carrington C. Winkler G.A. Huttley M.W. Smith R. Allikmets J.J. Goedert S.P. Buchbinder E. Vittinghof E. Gomperts et al. Genetic restriction of HIV-1 infection sand progression to AIDS by a deletion allele of the CKR5 structural gene Science 273 1996 1856-1861
22. R. Liu W.A. Paxton S. Choe D. Ceradini S.R. Martin R. Horuk M.E. MacDonald H. Stuhlmann R.A. Koup N.R. Landau Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection Cell 86 1996 367-377
23. J.M. Farber E.A. Berger HIV's response to a CCR5 inhibitor: I'd rather tighten than switch! Proc Natl Acad Sci USA 99 2002 1749-1751
24. C.G. Barber CCR5 antagonists for the treatment of HIV Curr Opin Investig Drugs 5 2004 851-861
25. K. Maeda H. Nakata H. Ogata Y. Koh T. Miyakawa H. Mitsuya The current status of, and challenges in, the development of CCR5 inhibitors as therapeutics for HIV-1 infection Curr Opin Pharmacol 4 2004 447-452
26. A. Trkola S.E. Kuhmann J.M. Strizki E. Maxwell T. Ketas T. Morgan P. Pugach S. Xu L. Wojcik J. Tagat et al. HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use Proc Natl Acad Sci USA 99 2002 395-400
27. D.A. Chistiakov Thyroid-stimulating hormone receptor and its role in Graves' disease Mol Genet Metab 80 2003 377-388
28. S. Mandala R. Hajdu J. Bergstrom E. Quackenbush J. Xie J. Milligan R. Thornton G.-J. Shei D. Card C. Keohahe et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists Science 296 2002 346-349
29. V. Brinkmann M.D. Davis C.E. Heise R. Albert S. Cottens R. Hof C. Bruns E. Prieschl T. Baumruker P. Hiestand et al. The immune modulator FTY720 targets sphingosine-1-phosphate receptors J Biol Chem 277 2002 21453-21457
30. J.L. Huang P.S. Gao R.A. Mathias T.C. Yao L.C. Chen M.L. Kuo S.C. Hsu B. Plunkett A. Togias K.C. Barnes et al. Sequence variants of the gene encoding chemoattractant receptor expressed on Th2 cells (CRTH2) are associated with asthma and differentially influence mRNA stability Hum Mol Genet 13 2004 2691-2697
31. K. Nagata K. Tanaka K. Ogawa K. Kemmotsu T. Imai O. Yoshie H. Abe K. Tada M. Nakamura K. Sugamura et al. Selective expression of a novel surface molecule by human Th2 cells in vivo J Immunol 162 1999 1278-1286
32. H. Hirai K. Tanaka O. Yoshie K. Ogawa K. Kenmotsu Y. Takamori M. Ichimasa K. Sugamura M. Nakamura S. Takano et al. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2 J Exp Med 193 2001 255-261
33. J.J. Murray A.B. Tonnel A.R. Brash L.J. Roberts II P. Gosset R. Workman A. Capron J.A. Oates Release of prostaglandin D2 into human airways during acute antigen challenge N Engl J Med 315 1986 800-804
34. R.V. Thakker Disorders of the calcium-sensing receptor Biochim Biophys Acta 1448 1998 166-170
35. A. Shenker Activating mutations of the lutropin choriogonadotropin receptor in precocious puberty Receptors Channels 8 2002 3-18
36. R. Seifert K. Wenzel-Seifert Defective Gi protein coupling in two formyl peptide receptor mutants associated with localized juvenile periodontitis J Biol Chem 276 2001 42043-42049
37. I.S. Farooqi J.M. Keogh G.S. Yeo E.J. Lank T. Cheetham S. O'Rahilly Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene N Engl J Med 348 2003 1085-1095